Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
HealthStream ( (HSTM) ) has provided an update.
On November 11, 2025, HealthStream announced that its Board of Directors approved a new share repurchase program, allowing the company to buy back up to $10 million of its outstanding common stock. This initiative, which is set to conclude by February 26, 2026, or when the maximum amount is spent, reflects HealthStream’s strategic financial management and could potentially enhance shareholder value, depending on market conditions and other factors.
The most recent analyst rating on (HSTM) stock is a Hold with a $27.00 price target. To see the full list of analyst forecasts on HealthStream stock, see the HSTM Stock Forecast page.
Spark’s Take on HSTM Stock
According to Spark, TipRanks’ AI Analyst, HSTM is a Neutral.
HealthStream’s overall stock score reflects strong financial performance and positive earnings call highlights, including record revenues and strategic acquisitions. However, technical analysis indicates bearish trends, and valuation metrics suggest the stock may be overvalued. The mix of positive financials and growth prospects with technical and valuation concerns results in a moderate overall score.
To see Spark’s full report on HSTM stock, click here.
More about HealthStream
HealthStream (Nasdaq: HSTM) is a leading healthcare technology platform company providing workforce solutions that empower healthcare professionals to deliver excellence in patient care.
Average Trading Volume: 187,366
Technical Sentiment Signal: Sell
Current Market Cap: $728.1M
For an in-depth examination of HSTM stock, go to TipRanks’ Overview page.